VI
ViroGates A/S
VIRO.CO · CPH
10.50 kr -3.67% (-0.40 kr)
1M +3.96%
Market Cap 97.5M kr
P/E Ratio -
Div. Yield -
ROE 54.79%
Piotroski F-Score Weak
2/9Valuation
13 /100
Expensive P/B 6.01x
P/S 11.41x
EV/EBITDA N/A
Growth
13 /100
Declining Book val. growth 6.44%
Rev. growth 29.58%
FCF growth N/A
Profitability
20 /100
Weak Net margin 88.59%
Op. margin 107.05%
FCF margin 142.17%
Quality
5 /100
Poor ROE 54.79%
ROA 34.27%
Asset turnover 0.39x
Debt
69 /100
Low Current ratio 6.90x
Int. coverage -19.48x
Debt/Equity 0.24x
Stability
44 /100
Moderate Rev. volatility 31.47%
EPS volatility 52.48%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VIRO.CO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Jakob Ole Knudsen
Employees
7
Headquarters
Birkerød
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report